Live Breaking News & Updates on Clinical Study Protocol
Stay updated with breaking news from Clinical study protocol. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
MEI Pharma Reports Initial Data from Clinical Study Evaluating ME-344 in Combination with Bevacizumab (Avastin®) in Relapsed Metastatic Colorectal Cancer Patients marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
MEI Pharma (MEIP) Reports Initial Data from Study of ME-344 in Combination with Bevacizumab streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Clinical stage biotechnology company PharmAust's (ASX: PAA) September quarter was highlighted by the commencement of its Motor Neurone Disease (MND) trial, recruiting its first four patients, as additional patients undergo screening to become the next-in-line. ....